English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23778585      線上人數 : 752
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34387


    標題: Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma
    作者: Yeh, Cheng-Fa
    Chan, Ti-Chun
    Ke, Hung-Lung
    Chen, Tzu-Ju
    Wu, Li-Ching
    Lee, Hsiang-Ying
    Wei, Yu-Ching
    Wu, Wen-Jeng
    Li, Chien-Feng
    Li, Wei-Ming
    貢獻者: Chi Mei Med Ctr, Div Gen Internal Med
    Chia Nan Univ Pharm & Sci, Dept Environm Engn & Sci
    Chi Mei Med Ctr, Dept Med Res
    Natl Hlth Res Inst, Natl Inst Canc Res
    Kaohsiung Med Univ Hosp, Dept Urol
    Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol
    Kaohsiung Municipal Tatung Hosp, Dept Urol
    Chi Mei Med Ctr, Dept Clin Pathol
    Kaohsiung Med Univ, Coll Med, Sch Med, Dept Pathol
    Kaohsiung Municipal Tatung Hosp, Dept Pathol
    Kaohsiung Med Univ, Ctr Liquid Biopsy & Cohort Res
    Minist Hlth & Welf Pingtung Hosp, Dept Urol
    關鍵字: ROR2
    bladder cancer
    upper tract urothelial carcinoma
    survival
    prognosis
    日期: 2021
    上傳時間: 2023-11-11 11:48:49 (UTC+8)
    出版者: MDPI
    摘要: We investigated the association of receptor tyrosine kinase-like orphan receptor 2 (ROR2) expression with clinicopathological features and oncologic outcomes in large urothelial carcinoma (UC) of the upper tract (UTUC) and urinary bladder (UBUC) cohorts. Through transcriptomic profiling of a published dataset (GSE31684), ROR2 was discovered to be the most upregulated gene during UC progression, focusing on the INK cascade (GO:0007254). Initially, the evaluation of ROR2 mRNA expression in 50 frozen UBUCs showed significantly upregulated levels in highstage UC. Moreover, high ROR2 immunoexpression significantly correlated with high tumor stage, high tumor grade, lymph node metastasis, and vascular invasion (all p < 0.05). In multivariate analysis, after adjusting for standard clinicopathological features, ROR2 expression status was an independent prognosticator of cancer-specific survival and metastasis-free survival in UTUC and UBUC (all p < 0.01). In the subgroup analysis, it also significantly predicted bladder tumor recurrence in non-muscle invasive UBUC. Furthermore, the GO enrichment analysis showed that fatty acid, monocarboxylic acid, carboxylic acid metabolic processes, negative regulation of neutrophil migration, and negative regulation of granulocyte and neutrophil chemotaxis were significantly enriched by ROR2 dysregulation. In conclusion, high ROR2 immunoexpression was associated with aggressive pathological characteristics in UC and independently predicted worse prognosis, suggesting it could play roles in clinical risk stratification and therapy decisions.
    關聯: BIOMEDICINES, v.9, n.8
    顯示於類別:[環境工程與科學系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    biomedicines9081054.pdf1912KbAdobe PDF39檢視/開啟
    index.html0KbHTML108檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋